BRPI0720564A2 - pirimidinonas biciclìcas e seus usos - Google Patents

pirimidinonas biciclìcas e seus usos Download PDF

Info

Publication number
BRPI0720564A2
BRPI0720564A2 BRPI0720564-3A BRPI0720564A BRPI0720564A2 BR PI0720564 A2 BRPI0720564 A2 BR PI0720564A2 BR PI0720564 A BRPI0720564 A BR PI0720564A BR PI0720564 A2 BRPI0720564 A2 BR PI0720564A2
Authority
BR
Brazil
Prior art keywords
formula
hydroxy
oxo
original document
document page
Prior art date
Application number
BRPI0720564-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Eric Dale Jones
Jonathan Alan Victor Coates
David Ian Rhodes
John Joseph Deadman
Nicholas Andrew Vandegraff
Lisa Jane Winfield
Neeranat Thienthong
Neil Choi
Katherine Macfarlane
William Issa
Original Assignee
Avexa Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2006907283A external-priority patent/AU2006907283A0/en
Application filed by Avexa Ltd filed Critical Avexa Ltd
Publication of BRPI0720564A2 publication Critical patent/BRPI0720564A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BRPI0720564-3A 2006-12-22 2007-12-21 pirimidinonas biciclìcas e seus usos BRPI0720564A2 (pt)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
AU2006907283A AU2006907283A0 (en) 2006-12-22 Bicyclic pyrimidinones and uses thereof
AU2006907283 2006-12-22
AU2007902479 2007-05-09
AU2007902479A AU2007902479A0 (en) 2007-05-09 Bicyclic pyrimidinones and uses thereof (2)
AU2007903401A AU2007903401A0 (en) 2007-06-25 Bicyclic pyrimidinodes and uses thereof (3)
AU2007903401 2007-06-25
AU2007904114 2007-07-31
AU2007904114A AU2007904114A0 (en) 2007-07-31 Bicyclic pyrimidinones and uses thereof (4)
PCT/AU2007/001980 WO2008077188A1 (en) 2006-12-22 2007-12-21 Bicyclic pyrimidinones and uses thereof

Publications (1)

Publication Number Publication Date
BRPI0720564A2 true BRPI0720564A2 (pt) 2011-08-16

Family

ID=39562030

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0720564-3A BRPI0720564A2 (pt) 2006-12-22 2007-12-21 pirimidinonas biciclìcas e seus usos
BRPI0722411-7A BRPI0722411A2 (pt) 2006-12-22 2007-12-21 pirimidinonas bicìclicas e seus usos

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0722411-7A BRPI0722411A2 (pt) 2006-12-22 2007-12-21 pirimidinonas bicìclicas e seus usos

Country Status (15)

Country Link
US (3) US8143268B2 (cg-RX-API-DMAC7.html)
EP (2) EP2114903B1 (cg-RX-API-DMAC7.html)
JP (2) JP5208962B2 (cg-RX-API-DMAC7.html)
KR (2) KR20100049698A (cg-RX-API-DMAC7.html)
CN (1) CN101880280B (cg-RX-API-DMAC7.html)
AR (2) AR064517A1 (cg-RX-API-DMAC7.html)
AT (1) ATE496898T1 (cg-RX-API-DMAC7.html)
AU (2) AU2007336703B9 (cg-RX-API-DMAC7.html)
BR (2) BRPI0720564A2 (cg-RX-API-DMAC7.html)
CA (1) CA2673183C (cg-RX-API-DMAC7.html)
DE (1) DE602007012308D1 (cg-RX-API-DMAC7.html)
DK (1) DK2114903T3 (cg-RX-API-DMAC7.html)
MX (1) MX2009006764A (cg-RX-API-DMAC7.html)
NZ (1) NZ577491A (cg-RX-API-DMAC7.html)
WO (1) WO2008077188A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011000149A (es) * 2008-07-02 2011-02-24 Avexa Ltd Compuestos que tienen propiedades antivirales.
WO2010000030A1 (en) * 2008-07-02 2010-01-07 Avexa Limited Thiazopyrimidinones and uses thereof
US8431581B2 (en) * 2008-07-02 2013-04-30 Avexa Limited Imidazopyrimidines and uses thereof
CN102336751A (zh) * 2010-07-16 2012-02-01 爱维艾珂瑟有限公司 新型抗病毒剂
ES2821394T3 (es) 2013-09-12 2021-04-26 Alios Biopharma Inc Compuestos de 7,8-dihidro-3H-pirazino[1,2-b]piridazin-3,5(6H)-diona y usos de los mismos
EP3082820B1 (en) 2013-12-19 2022-07-20 PTC Therapeutics, Inc. Methods for modulating the amount of rna transcripts
CA2979216A1 (en) 2015-03-11 2016-09-15 Alios Biopharma, Inc. Aza-pyridone compounds and uses thereof
EP4249472A3 (en) 2015-05-30 2023-12-13 PTC Therapeutics, Inc. Methods for modulating rna splicing
MX391850B (es) 2015-12-10 2025-03-19 Ptc Therapeutics Inc Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington
CA3043755A1 (en) 2016-11-28 2018-05-31 Ptc Therapeutics, Inc. Methods for modulating rna splicing
SG11201911615WA (en) 2017-06-05 2020-01-30 Ptc Therapeutics Inc Compounds for treating huntington's disease
BR112019026508A2 (pt) 2017-06-14 2020-07-14 Ptc Therapeutics, Inc. métodos para modificar o splicing do rna
MX2019015580A (es) 2017-06-28 2020-07-28 Ptc Therapeutics Inc Metodos para tratar la enfermedad de huntington.
WO2019005980A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. METHODS OF TREATING HUNTINGTON'S DISEASE
AU2019243048A1 (en) 2018-03-27 2020-10-15 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
BR112020026534A2 (pt) 2018-06-27 2021-03-23 Ptc Therapeutics, Inc. Compostos de heteroarila para o tratamento da doença de huntington
MX2020014098A (es) 2018-06-27 2021-05-27 Ptc Therapeutics Inc Compuestos heterocíclicos y de heteroarilo para tratar la enfermedad de huntington.
EP3814360B8 (en) 2018-06-27 2024-11-06 PTC Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
CA3162166A1 (en) 2019-12-02 2021-06-10 Storm Therapeutics Limited Polyheterocyclic compounds as mettl3 inhibitors
US12070445B2 (en) * 2021-08-27 2024-08-27 Wisconsin Alumni Research Foundation System and assay for monitoring production/release of membrane-lytic toxins in bacteria and compounds for modulating same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60107586T2 (de) 2000-09-20 2005-10-06 Schering Corp. Substituierte imidazole als duale histamine h1 und h3 agonisten oder antagonisten
SI1564210T1 (sl) 2002-11-20 2010-01-29 Japan Tobacco Inc 4-oksokinolinske spojine in njihova uporaba kot inhibitorji HIV integraze
JP4915734B2 (ja) 2003-12-18 2012-04-11 テイボテク・フアーマシユーチカルズ 呼吸器合胞体ウイルス複製阻害剤としてのアミノベンズイミダゾールおよびベンズイミダゾール
TW200526635A (en) * 2003-12-22 2005-08-16 Shionogi & Co Hydroxypyrimidinone derivative having HIV integrase inhibitory activity
CN101072758B (zh) 2004-10-12 2013-07-31 阿斯利康(瑞典)有限公司 喹唑啉衍生物
JP5116660B2 (ja) * 2005-03-31 2013-01-09 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・エルレ・エルレ Hivインテグラーゼ阻害剤
US7939537B2 (en) * 2005-10-04 2011-05-10 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. HIV integrase inhibitors

Also Published As

Publication number Publication date
US8859563B2 (en) 2014-10-14
JP5208962B2 (ja) 2013-06-12
ATE496898T1 (de) 2011-02-15
WO2008077188A1 (en) 2008-07-03
CN101880280A (zh) 2010-11-10
DK2114903T3 (da) 2011-04-18
KR20090097194A (ko) 2009-09-15
AR064517A1 (es) 2009-04-08
CA2673183A1 (en) 2008-07-03
US8207334B2 (en) 2012-06-26
HK1131615A1 (en) 2010-01-29
DE602007012308D1 (de) 2011-03-10
JP2010222370A (ja) 2010-10-07
EP2114903A4 (en) 2009-12-30
AU2007336703B2 (en) 2012-04-12
EP2114903B1 (en) 2011-01-26
AU2010201160A1 (en) 2010-04-15
US20110009366A1 (en) 2011-01-13
EP2269992A1 (en) 2011-01-05
AU2007336703A1 (en) 2008-07-03
CN101880280B (zh) 2014-07-16
US8143268B2 (en) 2012-03-27
US20120232035A1 (en) 2012-09-13
NZ577491A (en) 2011-06-30
JP2010513322A (ja) 2010-04-30
KR20100049698A (ko) 2010-05-12
US20100168063A1 (en) 2010-07-01
EP2114903A1 (en) 2009-11-11
CA2673183C (en) 2014-06-10
AU2007336703B9 (en) 2014-03-27
BRPI0722411A2 (pt) 2012-06-05
MX2009006764A (es) 2009-11-26
AR077043A2 (es) 2011-07-27

Similar Documents

Publication Publication Date Title
BRPI0720564A2 (pt) pirimidinonas biciclìcas e seus usos
ES3043457T3 (en) Rip1 inhibitory compounds and methods for making and using the same
JP5535204B2 (ja) 抗ウイルス特性を有する化合物
ES2607125T3 (es) Compuestos de tetrazolo[1,5-a]pirazina como inhibidores de receptores de histamina
JP7395730B2 (ja) ヘテロ環式rip1阻害化合物
JP2003321472A (ja) Grk阻害剤
CN102307875A (zh) 吡咯并嘧啶基axl激酶抑制剂
CA2729656A1 (en) Imidazopyrimidinones and uses thereof
JP7763538B2 (ja) Parp7阻害剤及びその使用
US20210261539A1 (en) Compound having bet inhibitory activity and preparation method and use therefor
ES2358550T3 (es) Pirimidinonas bicíclicas y sus usos.
CN101627019A (zh) 双环嘧啶酮以及其应用
HK1131615B (en) Bicyclic pyrimidinones and uses thereof
US20240343726A1 (en) Pyrrolopyridine-3- and 4-carboxamide compositions and methods for cellular proliferation

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: AVEXA LIMITED (AU)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]